Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Targovax presentation at Redeye Fight Cancer - Erik Digman Wiklund, CEO, Targovax
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Targovax presentation at Redeye Fight Cancer
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Invests in healthcare and technology in the US and Europe Funded in 1946|Stephen Knight,President and Managing Partner,F-Prime Capital (fka Fidelity Biosciences
00:10:00
Michael Walzer on October 7th and the Justness of Israel's Response|Michael Walzer, Professor, Institute for Advanced Study
00:10:00
Market Insights: Jonathan Corpina on Volatility, Fed Expectations, and Geopolitical Risks
00:10:00
Shelby Steele on Barack Obama: The Politics of Race and Identity|Shelby Steele
00:10:00
Red Pine Exploration's Drilling and Growth Plans
00:10:00
Seeing Machines’ technology powers products that need to deliver reliable real-time understanding of vehicle operators|Paul McGlone,CEO,Seeing Machines Ltd
00:10:00
Our mission is to enable our clients to achieve their financial and sustainability goals by providing superior investment returns and solutions | Karin van Baardwijk,Chief Executive Officer,Robeco Capital Gr. Fds. - RobecoSAM Sust. Healthy Living Eqs.
00:10:00
Jed Miller – Expert in Capital Relief Trades and Subscription Facilities at Cadwalader
00:10:00
Accelerating the Green Transition: Henrik Badin on VOW Green Metals' Innovative Initiatives | Henrik Badin, CEO, Vow ASA.
00:10:00
CEO Ronald Glibbery of Peraso Inc. provides a business update on new products, financials, and market strategies.
00:10:00
Rob Wiesenthal on Urban Air Mobility, BLADE’s Alliance with American Airlines, and Expansion into India | Rob Wiesenthal, CEO, Blade Air Mobility, Inc.
00:10:00
Robert Santangelo on IPO Market Trends and Investor Reactions